FORMATION AND REVERSE ACQUISITION OF MATINAS BIOPHARMA HOLDINGS - 2013 Private Placement (Details Textual) (USD $)
|
2 Months Ended | 1 Months Ended | 2 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 31, 2013
|
Aug. 31, 2013
Aegis Capital Corp [Member]
|
Aug. 31, 2013
Former preferred and common shareholders [Member]
|
Aug. 31, 2013
Private Placement [Member]
|
Aug. 31, 2013
Private Placement [Member]
Aegis Capital Corp [Member]
|
Aug. 31, 2013
Exercise Price One [Member]
Private Placement [Member]
Aegis Capital Corp [Member]
|
Aug. 31, 2013
Exercise Price Two [Member]
Private Placement [Member]
Aegis Capital Corp [Member]
|
Jul. 31, 2013
Herbert Conrad [Member]
|
Aug. 31, 2013
Herbert Conrad [Member]
Private Placement [Member]
|
|||||||
Formation And Reverse Acquisition [Line Items] | |||||||||||||||
Stock Issued During Period, Shares, New Issues | 9,000,000 | [1] | 15,000,000 | [2] | 351,563 | 250,000 | |||||||||
Warrants Issued For Purchase Of Common Stock | 2,250,000 | 1,500,000 | [1] | 7,500,000 | [2] | 750,000 | 1,500,000 | 250,000 | 125,000 | ||||||
Investment Warrants, Exercise Price | $ 2.00 | $ 2.00 | $ 1.00 | ||||||||||||
Proceeds from Issuance or Sale of Equity | $ 15,000,000 | $ 15,000,000 | $ 250,000 | ||||||||||||
Proceeds from Issuance of Common Stock | 11,983,000 | ||||||||||||||
Proceeds from Issuance of Warrants | 3,017,000 | 20,000 | |||||||||||||
Placement Agent Fees | 1,500,000 | ||||||||||||||
Non Accountable Expense Allowance | 450,000 | ||||||||||||||
Fair Value Of Warrants Issued | 1,300,000 | ||||||||||||||
Warrant Solicitation Fee Percentage | 5.00% | ||||||||||||||
Aggregate Common Stock Holding Percentage | 28.50% | [1] | 47.70% | [2] | |||||||||||
Aggregate Common Stock Holding Percentage Including Additional Share Issuance | 30.00% | ||||||||||||||
Payments of Stock Issuance Costs | 2,400,000 | ||||||||||||||
Placement Agent Cash Fees And Expenses | 1,950,000 | ||||||||||||||
External Legal Costs | $ 425,000 | ||||||||||||||
|